About SciClone Pharmaceuticals
SciClone Pharmaceuticals is a company based in Shanghai (China) founded in 1989 was acquired by BOC Investment in June 2017.. SciClone Pharmaceuticals has completed 1 acquisition, including NovaMed Pharmaceuticals.
- Headquarter Shanghai, China
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sciclone Pharmaceuticals Inc
-
Annual Revenue
$160.1 M2as on Dec 31, 2016
-
Net Profit
$30.73 M4as on Dec 31, 2016
-
EBITDA
$33.24 M11as on Dec 31, 2016
-
Latest Funding Round
-
Investors
Ascendent Capital Partners
& 3 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
BOC Investment
(Jun 07, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of SciClone Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SciClone Pharmaceuticals
SciClone Pharmaceuticals has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Ascendent Capital Partners, GL Capital and BOC Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Private equity investments in China are managed by BOC Investment.
|
Founded Year | Domain | Location | |
|
Private equity and private debt firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SciClone Pharmaceuticals
SciClone Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include NovaMed Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for oncology, cardiovascular, and CNS disorders are developed.
|
2005 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - SciClone Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sciclone Pharmaceuticals Comparisons
Competitors of SciClone Pharmaceuticals
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sciclone Pharmaceuticals
Frequently Asked Questions about SciClone Pharmaceuticals
When was SciClone Pharmaceuticals founded?
SciClone Pharmaceuticals was founded in 1989.
Where is SciClone Pharmaceuticals located?
SciClone Pharmaceuticals is headquartered in Shanghai, China.
What is the annual revenue of SciClone Pharmaceuticals?
Annual revenue of SciClone Pharmaceuticals is $160.1M as on Dec 31, 2016.
What does SciClone Pharmaceuticals do?
Sciclone is a specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. It has 7 marketed products in oncology and 1 product (Zadaxin) for HBV, HCV, immune system enhancement and sepsis. Product pipeline includes rapidfilm (CFDA reviewing CTA) and SGX942 (phase 2) in oncology; angiomax (CFDA review), neucardin (phase 3) and cleviprex (CTA application filed) in cardiovascular segment; and loramyc (In clinical testing) and vibativ (CTA application planning) in anti-infectives category.
How many acquisitions has SciClone Pharmaceuticals made?
SciClone Pharmaceuticals has made 1 acquisition, including NovaMed Pharmaceuticals.
Who are SciClone Pharmaceuticals's investors?
SciClone Pharmaceuticals has 4 investors. Key investors include Ascendent Capital Partners, GL Capital, BOC Investment, and CDH.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.